The role of antibodies, immunological memory and protection efficacy of the vaccination against Haemophilus influenza type B;El titulo de anticuerpos, la memoria inmunologica y la eficacia protectora de la vacuna frente a Haemophilus influenzae tipo B

Anales Espanoles de Pediatria

Volumn 50, Issue 4, 1999, Pages 341-345

  De Aristegui Fernandez, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

HAEMOPHILUS INFLUENZAE; IMMUNIZATION; IMMUNOLOGICAL MEMORY; INFECTION RISK; RADIOIMMUNOASSAY; REVIEW; RISK FACTOR; VACCINATION;

EID: 0033025983     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Barquet N, Arístegui J, Ruiz-Contreras J et al. Hib-EuroSud'95: the South exists. Vaccine 1996; 14:1569-1572.
2. Booy R, Kroll JS. Is Haemopilus influenzae finished? J Antimicrob Chemother 1997; 40:149-153.
3. Heath PT. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr Infect Dis J 1998; 17 (Supl):S117-122.
4. Peltola H. Haemophilus influenzae type b disease and vaccination in Europe: lessons learned. Pediatr Infect Dis J 1998; 17(Supl):S126-132.
5. Wenger JD. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatr Infect Dis J 1998; 17 (Supl):S132-136.
6. Frasch CE. Haemophilus influenzae type b conjugate and combination vaccines. Clin Immunother 1995; 4:376-386.
7. Ward JI, Zangwill KM. Haemophilus influenzae. En: Textbook of pediatric infectious diseases. RD Feigin, JD Cherry (eds). 4th ed. Philadelphia: WB Saunders Co. 1998: 1464-1482.
8. Heinzel FP. Antibodies. En: Principles and practice of infectious diseases. G Mandell, JE Bennett, R Dolin (eds). 4th ed. New York: Churchill Livingstone. 1995: 36-57.
9. Peltola H, Kayhty H, Sivonen A, Makela PH. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977; 60:730-737.
10. Peltola H, Kayhty H, Virtanen M, Makela PH. Prevention of Haemophilus influenzae type b bacteremic infections with capsular polysaccharide vaccine. N Engl J Med 1984; 310:1561-1566.
11. Kayhty H, Karanko V, Peltola H, Makela PH. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and response to reimmunisation: no evidence of immunologic tolerance of memory. Pediatrics 1984; 74:857-865.
12. Domínguez A, Prats G. Vacuna anti-Haemophilus influenzae tipo b. En: Vacunaciones preventivas. Principios y aplicaciones. L Salleras (ed). Barcelona: Masson SA. 1998: 311-336.
13. Kayhty H. Difficulties in establishing a serological correlate of protection after immunisation with Haemophilus influenzae conjugate vaccines. Biologicals 1994; 22:397-402.
14. Centers for Disease Control and Prevention. Recommendations for use of Haemophilus influenzae conjugate vaccines and a combined diphtheria, tetanus, perussis and Haemophilus b vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993; 42(RR-13):1-14.
15. Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 1992; 165(suppl 1):S49-52.
16. th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997.
17. Asociación Española de Pedsiatría: Calendario de Vacunaciones España 1995. An Esp Pediat 1995; 42:81.
18. Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Pediatrics 1995; 95:522-527.
19. Greenberg DP, Vadheim CM, Partridge et al. Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. J Infect Dis 1994; 170:76-81.
20. Ferreccio C, Clemens J, Avendano A et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphthria-tetanus toxoids-pertussis vaccine at two, four and six months of age. Peadiatr Infect Dis J 1991; 10:764-771.
21. Granoff DM, Anderson EL, Osterholm MT et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr 1992; 121:187-94.
22. Decker MD, Edwards KM, Bradley R, Palmer P. Comparative trials in infants of four conjugate Haemophilus influenzae type b vaccines. J Pediatr 1992; 120:184-189.
23. Holmes SJ, Fritzell B, Guito KP et al. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants. Am J Dis Child 1993; 147:832-836.
24. Barbour ML. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg Infect Dis 1996; 2:176-182.
25. Takala AK, Eskola J, Leinonen M et al. Reduction in oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991; 164:982-986.
26. Murphy TV, Pastor P, Medley F et al. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993; 122:517-523.
27. Eskola J, Peltola H, Takala AK et al. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med 1987; 317:717-722.
28. Eskola J, Kayhty H, Takala AK et al. A randomized, prospective field trial of a conjuagate vaccine in the protection of infant and young children against invasive Haemophilus influenzae type b disease. N Engl J Med 1990; 323:1381-1387.
29. Ward J, Brenneman G, Letson GW, Heyward WL. The Alaska H influenzae vaccine study group. Limited efficacy of a in Alaska native infants. N Engl J Med 1990; 323:1393-1401.
30. Kurikka S, Kayhty H, Saarinen L, Ronnberg PR, Eskola J, Makela PH. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. J Infect Dis 1995; 172:1268-1272.
31. Eskola J, Olander RM, Hovi T, Litmanen L, Peltola S, Kayhty H. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus infuenzae type b conjugate vaccine. Lancet 1996; 348:1688-1692.
32. Schmitt HJ, Zepp F, Muschenborn S et al. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations. Eur J Pediatr 1998; 157:208-214.
33. Scheifele D, Barreto L, Meekison W, Guasparini R, Friesen B. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid- pertussis vaccine-tetanus toxoid? Can Med Assoc J 1993; 149:1105-1112.
34. Kayhty H, Eskola J, Peltola H, Saarinen L, Makela PH. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. J Infect Dis 1992; 165(suppl):S165-166.
35. Zepp F, Schmitt HJ, Kaufhold A et al. Evidence for induction of polysaccharide specific B-cell-memory in the first year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DPTa-HBV combined vaccine. Eur J Pedaitr 1997; 156:18-24.
36. Arístegui J, Dal-Ré R, Garrote E, González A, Arrate JP, Pérez A. Assessment of the immunogenicity and reactogenicity of a quadrivalent diphtheria, tetanus, acellular pertussis and hepatitis B (DTPa-HBV) vaccine administered in a single injection with Haemophilus influenzae type b conjugate vaccine, to infants at 2,4 and 6 months of age. Vaccine 1998; 16:1976-1981.
37. Goldblatt D, Miller E, McCloskey N, Cartwright K. Immunological response to conjugate vaccines in infants: follow up study. Br Med J 1998; 16:1570-1571.
38. Goldblatt D, Fairley CK, Cartwright K, Miller E. Interchangeability of conjugated Haemophilus influenzae type b vaccines during primary immunisation of infants. Br Med J 1996; 312:817-818.
39. Deutsch J, Haschke F, Stögmann W, Willems P, Bogaerts H, Kaufhold A. Evidence that a 2-dose primary vaccination course of a combined DTPa-Hib vaccine induces immunological memory relevant for protection against Haemophilus influenzae type b disease. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. 1998; Abstract No G-33.